Quest for the right Drug
פרוסטימג'/דרקסימג' קיט להכנת TC99 (אם.אי.אי.) FROSSTIMAGE/DRAXIMAGE KIT FOR PREPARATION OF TC99M (MAA) (HUMAN SERUM ALBUMIN)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
תוך-ורידי : I.V
צורת מינון:
תמיסה להזרקה : SOLUTION FOR INJECTION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
ADVERSE REACTIONS The literature contains reports of deaths occurring after the administration of aggregated albumin to patients with pre-existing severe pulmonary hypertension. Instances of hemodynamic or idiosyncratic reactions to preparations of technetium Tc 99m albumin aggregated have been reported (See WARNINGS). Reporting of suspected adverse reactions Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form (https://sideeffects.health.gov.il). PHYSICAL CHARACTERISTICS Technetium Tc 99m decays by isomeric transition with a physical half-life of 6.02 hours.1 The principal photon that is useful for detection and imaging studies is listed in Table 1. Table 1 Principal Radiation Emission Data Mean % / Mean Energy Radiation Disintegration (keV) Gamma-2 89.07 140.5 External Radiation The specific gamma ray constant for technetium-99m is 5.44 µC•Kg-1•MBq-1•hr-1 (0.78 R/mCi- hr) at 1 cm. The first half value layer is 0.017 cm of lead. To facilitate control of the radiation exposure from megabecquerel amounts of this radionuclide, the use of a 0.25 cm thickness of lead will attenuate the radiation emitted by a factor of about 1,000. A range of values for the relative attenuation of the radiation resulting from the interposition of various thicknesses of lead is shown in Table 2. Table 2 Radiation Attenuation by Lead Shielding Shield Thickness Coefficient of (Pb) cm Attenuation 0.017 0.5 0.08 10-1 0.16 10-2 0.25 10-3 0.33 10-4 To correct for physical decay of this radionuclide, the fractions that remain at selected intervals after the time of calibration are shown in Table 3. Table 3 Physical Decay Chart of Technetium Tc 99m Half-Life 6.02 Hours Fraction Fraction Hours Remaining Hours Remaining 0* 1.000 5 0.562 1 0.891 6 0.501 2 0.794 8 0.398 3 0.708 10 0.316 4 0.631 12 0.251 *Calibration Time RADIATION DOSIMETRY The estimated absorbed radiation doses2 to various organs of an average adult patient (70 kg) from an intravenous injection of 148 MBq (4 mCi) of Technetium Tc 99m Albumin Aggregated Injection are shown in Table 4. Table 4 Estimated Absorbed Radiation Doses Organ/Tissue mGylper148 MBq rads/4 mCi Total body 0.60 0.060 Lungs 8.8 0.88 Liver 0.72 0.072 Spleen 0.68 0.068 Kidneys 0.44 0.044 Bladder wall 2.0 hr. void 1.2 0.12 4.8 hr. void 2.2 0.22 Testes 2.0 hr. void 0.24 0.024 4.8 hr. void 0.26 0.026 Ovaries 2.0 hr. void 0.30 0.030 4.8 hr. void 0.34 0.034 In paediatric patients, the radiation absorbed doses using the maximum recommended dose for lung imaging are based on 1.85 MBq/kg (50 µCi/kg) of body weight (except in the newborn where the maximum recommended dose 18.5 MBq [500 µCi] is used) and are shown in Table 5, which lists the maximum dose for paediatric patients from newborn to adults. Note the recommendations regarding the number of particles to be administered.
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף
עלון מידע לרופא
24.08.22 - עלון לרופאעלון מידע לצרכן
24.08.22 - החמרה לעלוןלתרופה במאגר משרד הבריאות
פרוסטימג'/דרקסימג' קיט להכנת TC99 (אם.אי.אי.)